For Immediate Release: August 06, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA issued a Safety Alert advising restaurants and retailers not to serve or sell, and consumers not to eat certain oysters from Lewis Bay, Massachusetts, due to potential
O Brasil e o Chile concluíram, na última quarta-feira (31/7), as negociações de uma iniciativa facilitadora de comércio para o setor de cosméticos. O acordo visa a convergência regulatória e o reconhecimento mútuo de documentos, facilitando o acesso aos mercados e impulsionando o comércio bilateral, sem comprometer a qualidade e a segurança dos produtos. Os principais
For Immediate Release: August 02, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “Advancing Clinical Trial Participation for the LGBTQIA+ Community,” by Christine Lee, Acting Associate Commissioner for Minority Health, Office of Minority Health and Health Equity.
For Immediate Release: July 30, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA is announcing the fiscal year (FY) 2025 user fee rates for importers approved to participate in the Voluntary Qualified Importer Program (VQIP) and accreditation and certification bodies interested
For Immediate Release: July 26, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA approved Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to include initiation of treatment, up-dosing and maintenance in individuals ages 1 through 3 years with a confirmed diagnosis of peanut
